PTEN and non-small cell lung carcinoma: In PTEN-deficient NSCLC, αPD-1 resistance can be effectively overcome by combining poly(I:C) + R848 with αTGF-β, which inhibits tumor growth and potentially converts αPD-1–resistant tumors into αPD-1–responsive tumors (94).